Adolescent and Young Adults with SCN8A Randomized trial with placebo or NBI-921352
The purpose of this clinical research study is: to find out if the use of study drug NBI-921352 along with the current therapies you are already receiving can help with the treatment of SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE) by looking at how it affects things such as your symptoms, quality of life, severity of seizures and frequency of seizures. to assess the pharmacokinetics (how the body absorbs, distributes, and gets rid of the study drug of NBI-921352 and to determine its effect on the plasma levels of concomitant (other) antiseizure medications and evaluated metabolites. to evaluate the safety and tolerability of NBI-921352.
- All genders
- Over 7 years old
- Volunteers with special conditions
- In Person
Who can participate?
Gender: All genders
Age: Over 7 years old
Volunteers: Volunteers with special conditions
Location: In Person
Will I be paid for my time?